Home 2018
Archives
Albiglutide Beats Placebo for Cardiovascular Events in T2DM
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Better Glycemic Control With Closed-Loop Insulin Delivery
Better glycemic control, reduced hypoglycemia risk for T1DM patients with suboptimal glycemic control
Nintedanib Plus Sildenafil No Better Than Nintedanib in IPF
No benefit with sildenafil in idiopathic pulmonary fibrosis with severe impairment in gas exchange
Partial Oral Abx Non-Inferior in Endocarditis on Left Side of Heart
Changing to oral antibiotics was non-inferior to continued intravenous antibiotic treatment
Doctors’ Intuition Linked to Number of Imaging Tests Ordered
Negative sentiment linked to increased utilization of imaging, especially at start of ICU stay
Experimental Drug Slows Mental Decline in Alzheimer’s Patients
However, the Phase 2 study of BAN2401 did not meet its primary end point
Focused Ultrasound May Briefly Open Blood-Brain Barrier
Finding could be a game-changer for the treatment of neurological diseases such as Alzheimer's
Most Women Who Freeze Eggs Motivated by Lack of Partner
Planning a career was the least common pathway to elective egg freezing
ADA: Closed-Loop Insulin Improves Glycemic Control
Better glycemic control than conventional subcutaneous insulin therapy in patients with T2DM
ADA: T1D, T2D, GDM Before 26 Weeks Tied to Higher ASD Risk
Increased risks of autism spectrum disorder in association with types 1, 2, gestational diabetes
